Remove Definition Remove Drug Development Remove Process Improvement
article thumbnail

Drug development trends: insight from Thermo Fisher’s Anil Kane

European Pharmaceutical Review

During CPHI Barcelona, EPR Editor Caroline Peachey asked Anil Kane, Global Head of Technical & Scientific Affairs, Pharma Services, at Thermo Fisher Scientific about the dynamic landscape of pharmaceutical drug development. What are the trends affecting drug development today?

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

11 The role of patient-centered evidence in the renegotiation process also requires greater definition. These sessions provide insight into how drugs function in real-world conditions—information that is vital to determining whether a treatment’s price reflects its true value across various patient populations.

article thumbnail

Data and digital is a force to reckon with when it comes to India

Express Pharma

She highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to harnessing India’s vast talent pool, particularly in the scientific and medical fields, in an interview with Viveka Roychowdhury India seems to have become a hub for pharma GCCs. With a long gestation period.